Terazosin, a repurposed GPR119 agonist, ameliorates mitophagy and β-cell function in NAFPD by inhibiting MST1-Foxo3a signaling pathway
Severe COVID-19 associated hyperglycaemia is caused by beta cell dysfunction: a prospective cohort study